Collegeville, PA, United States of America

Michael P Neeper

USPTO Granted Patents = 15 


Average Co-Inventor Count = 4.4

ph-index = 8

Forward Citations = 172(Granted Patents)


Location History:

  • Wayne, PA (US) (1993 - 1994)
  • Collegeville, PA (US) (1998 - 2011)

Company Filing History:


Years Active: 1993-2011

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Michael P. Neeper: Innovating in the Realm of TRPV2 Channels

Introduction

Michael P. Neeper, an accomplished inventor based in Collegeville, PA, holds an impressive portfolio of 15 patents. His work primarily focuses on the modulation of channels within canine cells, significantly contributing to the fields of pharmacology and biochemistry.

Latest Patents

Among his most recent innovations are two notable patents centered around the canine transient receptor potential V2 (cTRPV2) channel. The first patent discloses a recombinant canine TRPV2 channel, prepared through cDNA cloning and polymerase chain reaction techniques. This patent outlines the creation of expression systems for these channels and innovative assay methods utilizing these systems to evaluate compounds that may interact with the TRPV2 channel. The second patent details the discovery that specific cannabinoids can activate TRPV2 channel activity, leading to the development of new compositions and methods for screening and characterizing compounds that modulate TRPV2 activity.

Career Highlights

Throughout his career, Michael has worked with notable companies such as Merck & Company, Inc. and Janssen Pharmaceutica N.V. His experiences at these leading pharmaceutical companies have played a vital role in shaping his career as an inventor, allowing him to explore and develop breakthrough scientific innovations.

Collaborations

Michael has collaborated with talented coworkers, including Kathrin Ute Jansen and Joseph G. Joyce. These partnerships have enriched his research endeavors and contributed significantly to his inventions, showcasing the power of teamwork within the scientific community.

Conclusion

Michael P. Neeper's contributions to the field of TRPV2 channel research reflect his dedication to innovation and advancement. With numerous patents to his name, he continues to be a key figure in the scientific exploration of therapeutic potentials involving cannabinoid interactions and the modulation of the TRPV2 channel, paving the way for future research and developments in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…